Last reviewed · How we verify

Atm-Avi — Competitive Intelligence Brief

Atm-Avi (atm-avi) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: antibiotic. Area: Infectious Disease.

marketed antibiotic unknown Infectious Disease Live · refreshed every 30 min

Target snapshot

Atm-Avi (atm-avi) — Pfizer. ATM-AVI's mechanism of action is not specified on Wikipedia.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Atm-Avi TARGET atm-avi Pfizer marketed antibiotic unknown
SINECATECHINS SINECATECHINS marketed Polyphenols Unknown 2006-01-01
PODOFILOX PODOFILOX marketed Topical antiviral Unknown 1990-01-01
POLIDEXIDE SULFATE POLIDEXIDE SULFATE marketed Unknown Unknown 1974-01-01
SUTILAINS SUTILAINS marketed Unknown Unknown 1969-01-01
Riltozinameran 12 Years of age and older riltozinameran-12-years-of-age-and-older Pfizer marketed Unknown Unknown
Pf-07826390 pf-07826390 Pfizer marketed Unknown Unknown

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (antibiotic class)

  1. Pfizer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Atm-Avi — Competitive Intelligence Brief. https://druglandscape.com/ci/atm-avi. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: